Background: The Axxess stent belongs to the category of dedicated bifurcation lesion stents. It is a self-expanding DES, deployed at the level of the carina. The rationale behind this stent is to provide an anatomically tailored treatment for the bifurcation with maximum drug coverage and minimum overlap and deformation of the stent struts.
Our intention was to share our first experience with the self expandable drug eluting bifurcation stent Axxess. We aim to report procedural and in-patient outcomes of this stent in patients undergoing treatment to bifurcation coronary lesions in a real-world setting. Methods: We analysed 20 patients treated with Axxess stent for bifurcation lesions from September 2011 to September 2012. From them 17 (85%) were males, mean age 66. Results: Procedural success was achieved in all 20 (100%) patients. Optimal Axxess placement was reached in 18 (90%) patients -in one patients the device was placed after the bifurcation in the main branch and thus procedure was successfully ended with two additional stents, one in the main branch in overlapping with the Axxess stent and second DES at side branch as standard provisional T stenting ( Fig.1 ). In the second case the device landed just prior the bifurcation. In this case we placed other two DES in main and side branch in overlapping with the Axxess stent. Intraprocedural complication was seen in only one patient (instent thrombosis) resolved with adjunctions of IIb/IIIa inhibitors and balloon inflation. Femoral access was used in 12 (60%), predominantly during the first cases and the radial in 8 (40%) using sheathless catheter. Mean Rx time was 26,9. Conclusion: Our first experience with this novel bifurcation stent demonstrated its high success procedural and device rate. Moreover in case of not optimal placement the stent behaves as a normal DES and the procedure can be shifted without difficulties to classic two stent technic. Our experience also shows that the Axxess stent can be easily placed using radial approach adopting the sheathless catheter. Background: The aim of this study was to examine the mid-term angiographic result of T-stenting with small protrusion (TAP) as the bailout strategy for treating coronary bifurcation lesions. Methods: From 2009 to 2012, symptomatic patients who had severe coronary bifurcation stenoses were treated one-stent strategy using drug-eluting stents, with kissing balloon inflation whenever side branch impingement occurred. TAP was performed if either residual diameter stenosis !75%, type B or above dissection, or flow impairment was observed at the side branch. Restudy angiographic studies were performed for medium term luminal assessment. Results: There were 71 patients recruited who had a mean age of 61 AE 12 years, with male predominance (83%). MEDINA classification 1,1,1 lesions were found in over 60% of patients. The mean stent size and length in main vessel and side branch were 2.86 AE 0.43mm and 30 AE 12mmm, and 2.45 AE 0.26mm and 16 AE 6mmm, respectively. Restudy angiography was performed on 64 (90%) patients at 9.2 AE 3.9 months. Angiographic restenosis was observed in 8 (12.5%) patients; the late lumen loss in main vessel and side branch were 0.22 AE 0.19mm and 0.34 AE 0.37mm, respectively. Conclusion: The use of TAP as the bailout technique for treating coronary bifurcation lesions is associated with good angiographic outcomes, in terms of late lumen loss and restenosis, at 9 months. Background: The use of the DES for main branch in bifurcational coronary artery lesion or using DES main branch with regular balloon for the side branch did not show significant improvement at 6/12 follow up particularly for the side branch which still show significant rate restenosis. In bifurcation lesion with significant stenosis of both branches, the restenosis of side branch in high with either provisional or two stent techniques (15%). Methods: This registry enrolled 40 patients with coronary artery bifurcation lesion LAD/diagonal 28 patients, circumfles/obtuse marginal branch 8 patients with right coronary artery/ posterial descending, posterial lateral 4 patients received PCI with Paclitaxel-eluting balloon for the side branch and DES for main branch. Coronary angiogram at 6 months follow up achieved in 50%, a nuclear image was performed in 35% and 15% were following up clinically. The mean age group 60. Results: Procedure success was achieved to all patients the Pre PCI diameter stenosis was 85. Conclusion: This small study showed that this technique using DES for the main branch and DEB for the side branch is safe and effective at immediate and 6-12 months follow up with two patient restenosis and no acute and sub acute coronary artery thombosis. to our knowledge this study is reported for the first time. Background: Although there are data comparing the individual drug-eluting stents (DES) in unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI), there is lack of data in overall comparison of first versus second generation DESs. In this present study we are intended to compare the first and second generation DESs in PCI for ULMCA. Methods: A total 276 consecutive patients (pts) underwent PCI for ULMCA with DESs were enrolled for this study. Patients who received BMS (n¼7) were excluded from the study. Study population was classified as two groups; Patients who received first generation DESs (n¼189) and second generation DESs (n¼87). We analysed 6 months angiographic and 1 year clinical outcomes between the two groups. Results: Baseline clinical characteristics were comparable between the two groups. There was no significant difference in 6 month angiographic outcomes including follow up minimum luminal diameter (MLD), diameter stenosis (DS) and late lumen loss (LL) (p>0.05, Table 1 ) and 1 year clinical outcomes including mortality, repeat revascularization, stent thrombosis and major adverse cardiac events (MACE) between the two groups (p>0.05, Table 2 ). Conclusion: In PCI for ULMCA, first generation and second generation DESs were comparable regarding 6-month angiographic and 1-year clinical outcomes in a series of Asian population.
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